StonvexLoading…
StonvexStonvexStonvexCore line items from ASPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $23.85M | $4.14M | $433.03K | $0.00 |
Operating Income | $-59.91M | $-26.35M | $-16.04M | $-5.10M |
Net Income | $-159.84M | $-32.42M | $-16.29M | $-4.95M |
EPS (Diluted) | $-2.11 | $-0.63 | $-0.49 | $-0.18 |
Total Assets | $498.02M | $94.35M | $27.54M | $12.50M |
Total Liabilities | $235.12M | $43.18M | $8.71M | $2.68M |
Cash & Equivalents | $285.60M | $61.90M | $7.91M | $2.39M |
Free Cash Flow OCF − CapEx | $-47.43M | $-26.37M | $-7.74M | $-7.41M |
Shares Outstanding | 111.68M | 72.07M | 48.92M | 35.91M |